Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diagnostic difficulties and treatment implications.

R J Gumnit1

  • 1Comprehensive Epilepsy Program of Minnesota, Minneapolis 55414.

Epilepsia
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discontinuation of levetiracetam because of behavioral side effects: a case-control study.

Neurology·2003
Same author

Guidelines for essential services, personnel, and facilities in specialized epilepsy centers in the United States.

Epilepsia·2001
Same author

Financial aspects of introduction and application of new drugs and technologies.

Epilepsy research. Supplement·1996
Same author

Intracranial electrophysiologic studies.

Neuroimaging clinics of North America·1995
Same author

8-12 Hz rhythmic oscillations in human motor cortex during two-dimensional arm movements: evidence for representation of kinematic parameters.

Electroencephalography and clinical neurophysiology·1994
Same author

Standards for epilepsy surgery centers.

Epilepsy research. Supplement·1992
Same journal

Factors associated with rapid pediatric acute seizure emergency treatment: Quality Improvement in Time to Treat Status Epilepticus baseline cohort.

Epilepsia·2026
Same journal

Outcome trajectories after pediatric epilepsy surgery vary by biopsychosocial phenotypes.

Epilepsia·2026
Same journal

Comparative risk of epilepsy with SGLT2 inhibitors versus incretin-based therapies in type 2 diabetes.

Epilepsia·2026
Same journal

Long-term mortality after status epilepticus: A 5-year analysis study.

Epilepsia·2026
Same journal

The Epilepsy-Cog study: Methods to establish a harmonized study of late onset epilepsy in a metacohort of six population-based cohorts in the United States.

Epilepsia·2026
Same journal

Systematic review and meta-analysis of lifestyle modification interventions and their impact on seizure reduction and quality of life.

Epilepsia·2026
See all related articles

Advances in epilepsy classification and neurodiagnostics complicate, rather than simplify, matching antiepileptic drugs to seizure types. This challenges effective treatment selection and drug approval processes for epilepsy management.

Area of Science:

  • Neurology
  • Pharmacology
  • Epileptology

Background:

  • Recent advancements in neurodiagnostic techniques and epilepsy classification systems have improved seizure differentiation.
  • Paradoxically, these advancements have not simplified the process of selecting appropriate antiepileptic drugs (AEDs) for specific seizure types.

Purpose of the Study:

  • To examine the complexities in matching AEDs to specific seizure types.
  • To highlight how current classification systems can lead to diagnostic challenges and impact treatment decisions.
  • To discuss the implications for drug approval processes.

Main Methods:

  • The study reviews existing literature and classification systems for epileptic seizures.
  • It analyzes the potential for circular reasoning in linking seizure response to drug treatment with seizure type classification.

Related Experiment Videos

  • It considers the impact of etiological factors on future classification and treatment.

    • Main Results:

    • Complexities arise in differentiating seizure types, such as partial seizures with secondary generalization versus generalized tonic-clonic seizures, and complex partial seizures versus absence seizures with automatisms.
    • Faulty reasoning can occur when assuming drug response indicates a distinct seizure type, complicating diagnosis.
    • Future classification systems considering etiology may further complicate AED selection.

    Conclusions:

    • Current seizure classification systems present significant challenges in guiding appropriate antiepileptic drug selection.
    • The relationship between seizure classification, drug efficacy, and regulatory approval requires careful consideration.
    • Revising classification approaches is crucial for optimizing epilepsy treatment and drug development.